Intelligent Ultrasound Group PLC Notice of Results (5466T)
March 26 2021 - 2:00AM
UK Regulatory
TIDMIUG
RNS Number : 5466T
Intelligent Ultrasound Group PLC
26 March 2021
Intelligent Ultrasound Group plc
(the "Company")
Notice of results
Analyst briefing
Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound
artificial intelligence (AI) software and simulation company,
announces it will issue its final results for the year ended 31
December 2020 on Thursday, 15 April 2021.
The Company will host a briefing for analysts via ZOOM at 9.30am
on Thursday, 15 April. If you would like to register to dial in to
the analyst briefing or require further information, please contact
Walbrook PR on 020 7933 8780 or email
intelligentultrasound@walbrookpr.com.
For further information, please contact:
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny / Max Gould (Corporate
Finance)
Michael Johnson / Julian Morse
(Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44
(0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market. Based in
Cardiff in the UK and Atlanta in the US, the Group operates two
divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make
ultrasound machines smarter and more accessible. Products in the
market include ScanNav Assist, which uses machine-learning based
algorithms to automatically identify and grade ultrasound images.
GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound
machine incorporates the ScanNav Assist AI technology and has
received 510(k) clearance from the FDA for sale in the USA.
SonoLyst is the world's first fully integrated AI tool that
recognises the 20 views recommended by the International Society of
Ultrasound in Obstetrics and Gynaecology mid-trimester practice
guidelines for fetal imaging.
Products in development include ScanNav Anatomy PNB, which aims
to simplify ultrasound-guided needling by providing the user with
real-time AI-based anatomy highlighting software for a range of
medical procedures. ScanNav Anatomy has been submitted for CE and
FDA regulatory approval.
Simulation Division
Focusses on hi-fidelity ultrasound education and training
through simulation. Its three main products are the ScanTrainer
OBGYN training simulator, the HeartWorks echocardiography training
simulator and the BodyWorks Eve Point of Care and Emergency
Medicine training simulator. To date over 1,000 simulators have
been sold to over 600 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORMZGZFVKGGMZM
(END) Dow Jones Newswires
March 26, 2021 03:00 ET (07:00 GMT)
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Apr 2023 to Apr 2024